Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
EIPG Newsletter
Politics & Business
Politics & Business
Biosimilars: the strategic imperative to balance between the needs for innovation...
Giuliana Miglierini
-
15 May 2019
0
Transforming Big Pharma’s model
Giuliana Miglierini
-
16 April 2019
0
Horizon Europe: time to look at the future of European research
Giuliana Miglierini
-
21 March 2019
0
Emerging trends for the pharmaceutical market
Giuliana Miglierini
-
20 February 2019
0
Inequalities in the access to healthcare in Europe
Giuliana Miglierini
-
15 January 2019
0
Hard Brexit, soft Brexit, no Brexit?
Giuliana Miglierini
-
11 December 2018
0
The peril road of the SPC manufacturing waiver
Giuliana Miglierini
-
21 November 2018
0
The business of AI-based sharing of healthcare data
Giuliana Miglierini
-
23 October 2018
0
The sustainability of the business model for advanced therapies
Giuliana Miglierini
-
20 September 2018
0
Italy has overtaken Germany for pharmaceutical production
Redazione
-
4 September 2018
0
1
2
Page 1 of 2
